216 related articles for article (PubMed ID: 25392238)
1. Recommendations for validation of LC-MS/MS bioanalytical methods for protein biotherapeutics.
Jenkins R; Duggan JX; Aubry AF; Zeng J; Lee JW; Cojocaru L; Dufield D; Garofolo F; Kaur S; Schultz GA; Xu K; Yang Z; Yu J; Zhang YJ; Vazvaei F
AAPS J; 2015 Jan; 17(1):1-16. PubMed ID: 25392238
[TBL] [Abstract][Full Text] [Related]
2. Bioanalytical method validation considerations for LC-MS/MS assays of therapeutic proteins.
Duggan JX; Vazvaei F; Jenkins R
Bioanalysis; 2015; 7(11):1389-95. PubMed ID: 26110712
[TBL] [Abstract][Full Text] [Related]
3. Progress in high-sensitivity hybrid LC-MS/MS methods for the bioanalysis of protein drugs and performance tests for their validation.
Duggan JX
Bioanalysis; 2018 Jul; 10(13):983-986. PubMed ID: 29993264
[No Abstract] [Full Text] [Related]
4. Liquid chromatography coupled with tandem mass spectrometry for the bioanalysis of proteins in drug development: practical considerations in assay development and validation.
Liu G; Ji QC; Dodge R; Sun H; Shuster D; Zhao Q; Arnold M
J Chromatogr A; 2013 Apr; 1284():155-62. PubMed ID: 23466204
[TBL] [Abstract][Full Text] [Related]
5. Intact mAb LC-MS for drug concentration from pre-clinical studies: bioanalytical method performance and in-life samples.
Kellie JF; Alelyunas YW; Albert J; Schneck NA; Chen Z; Sychterz CJ; Edwards I; Shion H; Wrona MD; Szapacs ME
Bioanalysis; 2020 Oct; 12(19):1389-1403. PubMed ID: 32975433
[No Abstract] [Full Text] [Related]
6. Application of in-sample calibration curve methodology for regulated bioanalysis: Critical considerations in method development, validation and sample analysis.
Yuan L; Gu H; Zeng J; Pillutla RC; Ji QC
J Pharm Biomed Anal; 2020 Jan; 177():112844. PubMed ID: 31491659
[TBL] [Abstract][Full Text] [Related]
7. Comparison of bioanalytical methods for the quantitation of PEGylated human insulin.
de Dios K; Manibusan A; Marsden R; Pinkstaff J
J Immunol Methods; 2013 Oct; 396(1-2):1-7. PubMed ID: 23933323
[TBL] [Abstract][Full Text] [Related]
8. Eliminating Preparation of Multisample External Calibration Curves and Dilution of Study Samples Using the Multiple Isotopologue Reaction Monitoring (MIRM) Technique in Quantitative LC-MS/MS Bioanalysis.
Gu H; Zhao Y; DeMichele M; Zheng N; Zhang YJ; Pillutla R; Zeng J
Anal Chem; 2019 Jul; 91(13):8652-8659. PubMed ID: 31180205
[TBL] [Abstract][Full Text] [Related]
9. LC-MS quantification of protein drugs: validating protein LC-MS methods with predigestion immunocapture.
Duggan J; Ren B; Mao Y; Chen LZ; Philip E
Bioanalysis; 2016 Sep; 8(18):1951-64. PubMed ID: 27532431
[TBL] [Abstract][Full Text] [Related]
10. LC-MS bioanalysis of intact proteins and peptides.
Kang L; Weng N; Jian W
Biomed Chromatogr; 2020 Jan; 34(1):e4633. PubMed ID: 31257628
[TBL] [Abstract][Full Text] [Related]
11. Current advances and strategies towards fully automated sample preparation for regulated LC-MS/MS bioanalysis.
Zheng N; Jiang H; Zeng J
Bioanalysis; 2014 Sep; 6(18):2441-59. PubMed ID: 25384595
[TBL] [Abstract][Full Text] [Related]
12. LC-MS-based quantification of intact proteins: perspective for clinical and bioanalytical applications.
van den Broek I; van Dongen WD
Bioanalysis; 2015; 7(15):1943-58. PubMed ID: 26295992
[TBL] [Abstract][Full Text] [Related]
13. Bioanalytical method development and validation: Critical concepts and strategies.
Moein MM; El Beqqali A; Abdel-Rehim M
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Feb; 1043():3-11. PubMed ID: 27720355
[TBL] [Abstract][Full Text] [Related]
14. Bioanalytical approaches to analyzing peptides and proteins by LC--MS/MS.
Ewles M; Goodwin L
Bioanalysis; 2011 Jun; 3(12):1379-97. PubMed ID: 21679032
[TBL] [Abstract][Full Text] [Related]
15. Bioanalytical LC-MS/MS validation of therapeutic drug monitoring assays in oncology.
van Nuland M; Rosing H; Schellens JHM; Beijnen JH
Biomed Chromatogr; 2020 Jan; 34(1):e4623. PubMed ID: 31215049
[TBL] [Abstract][Full Text] [Related]
16. Critical considerations for immunocapture enrichment LC-MS bioanalysis of protein therapeutics and biomarkers.
Zhao Y; Gu H; Zheng N; Zeng J
Bioanalysis; 2018 Jul; 10(13):987-995. PubMed ID: 29972311
[TBL] [Abstract][Full Text] [Related]
17. Validation of bioanalytical LC-MS/MS assays: evaluation of matrix effects.
Van Eeckhaut A; Lanckmans K; Sarre S; Smolders I; Michotte Y
J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Aug; 877(23):2198-207. PubMed ID: 19179125
[TBL] [Abstract][Full Text] [Related]
18. Validation of LC-MS/MS bioanalytical methods for protein therapeutics.
Vazvaei F; Duggan JX
Bioanalysis; 2014; 6(13):1739-42. PubMed ID: 25157481
[No Abstract] [Full Text] [Related]
19. IQ consortium perspective: complementary LBA and LC-MS in protein therapeutics bioanalysis and biotransformation assessment.
Kaur S; Bateman KP; Glick J; Jairaj M; F Kellie J; Sydor J; Zeng J
Bioanalysis; 2020 Feb; 12(4):257-270. PubMed ID: 32096432
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS bioanalytical challenge: ultra-high sensitivity assays.
Aubry AF
Bioanalysis; 2011 Aug; 3(16):1819-25. PubMed ID: 21877891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
